The Kubasik Lectureship Award was instituted in 1991 by the AACC Upstate New York Section in memory of Dr Norman P. Kubasik, Director of Chemistry at the Genesee Hospital in Rochester, NY. The award is presented annually at the fall meeting to an individual who exemplifies Dr Kubasik's interest in education, in teaching and in supporting young technologists and investigators, or to someone with a reputation as an outstanding scientist in a discipline related to clinical chemistry. The award consists of an honorarium ($500), a clock, and a plaque.
2017: Andy Hoofnagle, PhD (Seattle, WA); Protein Testing by Mass Spectrometry
2016: Ann Gronowski, PhD (St. Louis, MO); Direct to Consumer Testing; Is it ethical to allow patients to order tests?
2015: Marilyn Heustis, (Baltimore, MD); Marijuana: From the Street to the Clinic.
2014: Larry D. Bowers, PhD (Colorado Springs, CO); Lessons learned from 22 Years of Testing for Performance Enhancing Drugs in Olympic Sport.
*awarded fall 2015, due to change in 2014 fall meeting date
2013: Not Awarded
2012: Corinne R. Fantz, PhD (Atlanta, GA), Connecting patients with their lab results via patient portals: Opportunities and Controversies
2011: Jack H. Ladenson, PhD (St. Louis, MO)
Experiences with Heart and Brain Biomarkers
2010: Daniel W. Chan, PhD (Baltimore, MD)
Tumor Markers: Past, Present and Future
2009: Michael Laposata, M.D., Ph.D (Nashville, TN): Laboratory Tests in the Diagnosis of Bleeding and Thrombotic Disorders
2008: Larry A. Broussard, Ph.D (New Orleans, LA): The Clinical Toxicology Laboratory's Role in Rock and Roll Heaven
2007: Nader Rifai, PhD (Boston, MA)
Laboratory Issues in hs-CRP Evaluation
2006: David B. Sacks, MD, MB, ChB, FRCPath, FACB (Boston, MA) Diabetes 2006: The role of the laboratory
2005: Carl A. Burtis, PhD (Oak Ridge, TN)
The History of the Future of the Clinical Laboratory
2004: Fred A. Apple, PhD (Minneapolis, MN)
Cardiovascular Disease – Science and Cardiac Marker Guidelines
2003: Roland Valdes, Jr. PhD (Louisville, KY)
Pharmacogenomics in Laboratory Medicine
2002: D. Joe Boone, PhD (Atlanta, GA)
Is it Safe to Have a Laboratory Test?
David E. Bruns, MD (Charlottesville, VA)
Evidence-Based Laboratory Medicine: Why is it Relevant?
2000: Robert H. Christenson, PhD (Baltimore, MD)
Use of Biochemical Markers for Assessment of Coronary Syndromes
1999: George Klee, MD (Rochester, MN)
1998: Eleftherios Diamandis, MD (Toronto, ONT)
1997: Larry J. Kricka, DPhil (Philadelphia, PA)
Ultrasensitive Immunoassay Methods
1996: Graham Ellis, PhD (Toronto, ONT)
How the Clinical Chemistry Laboratory can Help the Pediatric Endocrinologist to Assess Children's Growth
1995: David M. Goldberg, MD, PhD (Toronto, ONT)
Biochemical Mechanism for the Cardioprotective Effect of Alcoholic Beverages
1994: Theodore Peters, PhD (Cooperstown, NY)
1992: Leslie M. Shaw, PhD (Philadelphia, PA)
Monitoring Cyclosporine Immunosupressive Therapy
1991: Laurence M. Demers, PhD (Hershey, PA)
The Value of Tumor Associated Antigens
Norman P. Kubasik, PhD (1942-1991)
Norman Kubasik attended Rochester Institute of Technology, received his Bachelor of Science Degree from State University College of Fredonia (1965), and received his Doctorate in Biochemistry (1970) from SUNY Upstate Medical Center in Syracuse. Norm was the Director of Clinical Chemistry and Laboratory Services at Genesee Hospital, Rochester, up to the time of his death early in 1991. He was affiliated with many associations and colleges including being the Chairman of the Rochester Hospital Association of Clinical Chemists, an Assistant Professor of Biochemistry at University of Rochester School of Medicine and Dentistry, Professor of Clinical Sciences at Rochester Institute of Technology. In addition to his many affiliations he received the Somogyi-Sendroy Award for distinguished contributions in 1989 from the Upstate NY AACC. His laboratory interests focused primarily on endocrinology and immunoassay and he traveled widely as a consultant for diagnostic products at many universities and hospitals world-wide.